Results 101 to 110 of about 13,449 (262)
ABSTRACT Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially life‐threatening arrhythmic disorder typically treated with beta‐blockers and, occasionally, with flecainide. Methods All patients underwent genetic testing, electrocardiogram, echocardiogram, and exercise testing.
Fernando Wangüemert‐Perez +9 more
wiley +1 more source
Smartphone heart monitors in pediatric CIEDs: A pilot study. Smartphone heart monitors did not induce EMI in children with CIEDs, enabling reliable heart rate measurement and accurate identification of ventricular non‐captures. ABSTRACT Background Portable heart monitors enable on‐demand electrocardiogram (ECG) recordings and enhance symptom‐rhythm ...
Chun‐Lok Ho +3 more
wiley +1 more source
This article is prepared on the basis of presentations given at the Annual Scientific Sessions of the European Society of Cardiology 2002 in Berlin, Germany.
Ashish Nabar
doaj
ABSTRACT Background In patients with structural heart disease (SHD) and moderately impaired left ventricular ejection fraction (LVEF > 35%), data on outcomes after ventricular tachycardia (VT) ablation remain limited. This analysis focuses on VT recurrence after ablation in patients presenting with sustained VT and LVEF > 35% within a secondary ...
Said‐Elias Waezsada +14 more
wiley +1 more source
ICD in cardiac resinhronization therapy
Background: Patients with advanced heart failure bears bad prognosis, despite modern medical treatment year mortality rate spans from 30 up to 70%.
Damijan Vokač
doaj
Intra-Abdominal Hemorrhage Triggering Inappropriate Therapy From a Subcutaneous Defibrillator
The SMART Pass filter (Boston Scientific) aims to reduce inappropriate shocks (IASs) from subcutaneous implantable cardioverter-defibrillators by filtering out low-frequency signals such as T waves.
Michael M. Malaty, MBBS +4 more
doaj +1 more source
Defibrillation thresholds testing of implantable cardioverter-defibrillators at implantation
I read with interest the reports on defibrillation testing (DFT) during implantable cardioverter-defibrillator (ICD) implantation published recently in JACC ([1,2][1]). There is a significant, albeit low, risk to serious complications including death during DFT testing.
openaire +1 more source
ABSTRACT Introduction Patients with repaired tetralogy of Fallot (rTOF) remain at risk of ventricular tachycardia (VT). This risk is most commonly related to slow conduction within the septal isthmus, which is defined as the region between the ventricular septal defect (VSD) patch and adjacent valvular annuli.
Yuki Matsuoka +8 more
wiley +1 more source
Background Battery longevity in high‐voltage devices (HVDs), specifically implantable cardioverter‐defibrillators (ICDs) and cardiac resynchronization therapy‐defibrillators (CRT‐Ds), is critical for reducing the frequency of generator replacements ...
Kotaro Nishino +16 more
doaj +1 more source

